Santos Coy-Arechavaleta Andrea, Alvarado-Yaah Julio Elias, Uribe-Noguez Luis Antonio, Guerra-Castillo Francisco Xavier, Santacruz-Tinoco Clara Esperanza, Ramón-Gallegos Eva, Muñoz-Medina José Esteban, Fernandes-Matano Larissa
Escuela Nacional de Ciencias Biológicas, Programa de Doctorado en Ciencias en Biomedicina y Biotecnología Molecular, Instituto Politécnico Nacional-IPN, Mexico City 11350, Mexico.
Laboratorio Central de Epidemiología, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.
Microorganisms. 2024 Feb 20;12(3):428. doi: 10.3390/microorganisms12030428.
SARS-CoV-2 has spread throughout the world since 2019, changing in its genome and leading to the appearance of new variants. This gave it different evolutionary advantages, such as greater infectivity and/or a greater ability to avoid the immune response, which could lead to an increased severity of COVID-19 cases. There is no consistent information about the viral load that occurs in infection with the different SARS-CoV-2 variants, hence, in this study we quantify the viral load of more than 16,800 samples taken from the Mexican population with confirmed diagnosis of COVID-19 and we analyze the relation between different demographic and disease variables. We detected that the viral load caused by different variants differs only in the first two days after the onset of symptoms, being higher when infections are caused by the delta variant and lower when caused by omicron. Furthermore, the viral load appears to be higher in outpatients compared to hospitalized patients or in cases of death. On the other hand, no differences were found in the viral load produced in vaccinated and unvaccinated patients, nor did it differ between genders.
自2019年以来,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)已在全球传播,其基因组发生变化,导致新变种出现。这赋予了它不同的进化优势,如更强的传染性和/或更强的逃避免疫反应的能力,这可能导致新冠肺炎病例的严重程度增加。关于感染不同SARS-CoV-2变种时出现的病毒载量,目前尚无一致的信息,因此,在本研究中,我们对从确诊新冠肺炎的墨西哥人群中采集的16800多个样本的病毒载量进行了量化,并分析了不同人口统计学和疾病变量之间的关系。我们检测到,不同变种引起的病毒载量仅在症状出现后的前两天有所不同,由德尔塔变种引起的感染时病毒载量较高,由奥密克戎变种引起的感染时病毒载量较低。此外,门诊患者的病毒载量似乎高于住院患者或死亡病例。另一方面,接种疫苗和未接种疫苗的患者产生的病毒载量没有差异,不同性别之间也没有差异。